Fosinopril Sodium Tablet
Product Images NDC 69097-856

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Fosinopril Sodium (NDC 69097-856). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (9d869f7c 9b5a 47aa 9a82 35a0f86112b2 01)

Chemical structure of Fosinopril, the active ingredient in Fosinopril Sodium tablets. The diagram shows the molecular arrangement including rings, chains, and functional groups pertinent to Fosinopril.*

FDA Label Image

Image (9d869f7c 9b5a 47aa 9a82 35a0f86112b2 02)

A data table titled 'Clinical Adverse Events in Placebo-Controlled Trials (Hypertension)' showing incidence and discontinuation percentages for Fosinopril Sodium (N=688) and placebo (N=184). It reports incidences for cough, dizziness, and nausea/vomiting under both groups with corresponding discontinuation rates.*

FDA Label Image

Image (9d869f7c 9b5a 47aa 9a82 35a0f86112b2 03)

A data table showing clinical adverse events incidence and discontinuation rates during placebo-controlled trials for heart failure comparing Fosinopril Sodium (N=361) and placebo (N=373). Events listed include dizziness, cough, hypotension, musculoskeletal pain, nausea/vomiting, diarrhea, chest pain, upper respiratory infection, orthostatic hypotension, subjective cardiac rhythm disturbances, and weakness, with percentages for incidence and discontinuation for each group.*

FDA Label Image

Image (Fosinopril Label 10mg)

Fosinopril Sodium Tablets, USP 10 mg label for a 90-tablet bottle by Cipla USA Inc. The label includes storage instructions, dosage directions, and manufacturer information. It also displays a QR code and bar code with serialization details such as GTIN, serial number, expiration, and lot number placeholders.*

FDA Label Image

Image (Fosinopril Label 20mg)

Label for Fosinopril Sodium Tablets USP, 20 mg, packaged with 90 tablets. The label includes dosage strength prominently in green, the NDC 69097-857-05, and states the product is Rx only. Manufactured by InvaGen Pharmaceuticals, a Cipla Ltd. subsidiary, and distributed by Cipla USA Inc., Warren, NJ. It also provides storage instructions, container requirements, and a barcode with a QR code for identification.*

FDA Label Image

Image (Fosinopril Label 40mg)

Label for Fosinopril Sodium Tablets, USP 40 mg, featuring a package size of 90 tablets. The label includes storage instructions, dosage references, and safety warnings. It is manufactured by InvaGen Pharmaceuticals, a subsidiary of Cipla Ltd., and labeled for Cipla USA, Inc. The label displays the NDC 69097-858-05 and a barcode along with a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.